Search results for "Emerging infections"

showing 5 items of 5 documents

Intestinal tuberculosis in a child living in a country with a low incidence of tuberculosis : a case report

2014

Background: Relatively common in adults, intestinal tuberculosis is considered rare in children and adolescents. The protean manifestations of intestinal tuberculosis mean that the diagnosis is often delayed (sometimes even for years), thus leading to increased mortality and unnecessary surgery. The main diagnostic dilemma is to differentiate intestinal tuberculosis and Crohn’s disease because a misdiagnosis can have dramatic consequences. Case presentation: A 13-year-old Caucasian, Italian female adolescent attended the Emergency Department complaining of abdominal pain, a fever of up to 38°C, night sweats, diarrhea with blood in stool, and a weight loss of about three kilograms over the p…

Abdominal painBiopsymedicine.medical_treatmentAntitubercular AgentsCase ReportInflammatory bowel diseaseGastroenterologySettore MED/38 - Pediatria Generale E SpecialisticaCrohn DiseaseLaparotomyWhole Body ImagingMedicine(all)biologymedicine.diagnostic_testIleal DiseasesIncidenceGeneral MedicineEmerging infectionsTreatment OutcomeItalyIntestinal tuberculosisAbdominal ultrasonographyDrug Therapy CombinationFemalemedicine.symptommedicine.medical_specialtyMiliary tuberculosisTuberculosisAdolescentGeneral Biochemistry Genetics and Molecular BiologyDiagnosis DifferentialMycobacterium tuberculosisPredictive Value of TestsInternal medicineGastrointestinal infectionsmedicineHumansTuberculosisDiagnostic ErrorsEmerging infections Gastrointestinal infections Intestinal tuberculosis Mycobacterium tuberculosis TuberculosisTuberculosis MiliaryBiochemistry Genetics and Molecular Biology(all)business.industryMycobacterium tuberculosisAbdominal distensionmedicine.diseasebiology.organism_classificationSurgeryTuberculosis GastrointestinalTomography X-Ray Computedbusiness
researchProduct

Chaperoning the Mononegavirales: Current Knowledge and Future Directions

2018

This article belongs to the Special Issue Breakthroughs in Viral Replication.

0301 basic medicineProtein Foldingrespiratory syncytial viruslcsh:QR1-502ReviewRespiratory syncytial virusVirus Replicationmedicine.disease_causelcsh:MicrobiologyHsp70Ebola virusantiviralsChaperonesMononegaviralesOrder MononegaviralesbiologyAntivirals<i>Mononegavirales</i>Hsp90Respiratory Syncytial VirusesInfectious DiseasesMumps virusHost-Pathogen InteractionsProtein foldingHsp90biology_otherComputational biologyAntiviral Agents03 medical and health sciencesEmerging infectionsVirologymedicineHumanschaperonesHSP70 Heat-Shock Proteinsrabies virusHSP90 Heat-Shock ProteinsEbola virusObligatebiology.organism_classificationCCT030104 developmental biologyMeasles virusRabies virusChaperone (protein)measles virusbiology.proteinmumps virusMononegaviralesMolecular ChaperonesViruses
researchProduct

Chaperoning the &lt;em&gt;Mononegavirales&lt;/em&gt;: Current Knowledge and Future Directions

2018

The order Mononegavirales harbors numerous viruses of significant relevance for human health, including both established and emerging infections. Currently, vaccines are only available for a small subset of these viruses and antiviral therapies remain limited. Being obligate cellular parasites, viruses must utilize the cellular machinery for their replication and spread. Therefore, targeting cellular pathways used by viruses can provide novel therapeutic approaches. One of the key challenges confronted by both hosts and viruses alike is the successful folding and maturation of proteins. In cells, this task is faced by cellular molecular chaperones, a group of conserved and abundant proteins…

Order MononegaviralesEbola virusbiologyObligateComputational biologybiology.organism_classificationmedicine.disease_causeHsp90Emerging infectionsChaperone (protein)medicinebiology.proteinProtein foldingMononegavirales
researchProduct

Re-Emerging Vaccine-Preventable Diseases in War-Affected Peoples of the Eastern Mediterranean Region—An Update

2017

For the past few decades, the Eastern Mediterranean Region has been one area of the world profoundly shaped by war and political instability. On-going conflict and destruction have left the region struggling with innumerable health concerns that have claimed the lives of many. Wars, and the chaos they leave behind, often provide the optimal conditions for the growth and re-emergence of communicable diseases. In this article, we will highlight three of the major re-emerging vaccine preventable diseases cholera, measles, and polio, in four countries of the Eastern Mediterranean Region that are currently affected by war leading to a migration crisis: Iraq, South Sudan, Syria, and Yemen. The re…

Economic growthRefugee030231 tropical medicinere-emerging infections vaccine-preventable diseases refugees poliomyelitis measles choleracholeraContext (language use)ReviewMeasles03 medical and health sciences0302 clinical medicineEnvironmental protectionmedicinemeasles030212 general & internal medicinePolitical instabilityNational healthbusiness.industrylcsh:Public aspects of medicinePublic Health Environmental and Occupational Healthlcsh:RA1-1270medicine.diseaserefugeesre-emerging infectionshumanitiesPoliomyelitisEastern mediterraneanvaccine-preventable diseasesVaccine-preventable diseasesPublic HealthbusinesspoliomyelitisFrontiers in Public Health
researchProduct

Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats.

2013

Substantial improvements in the safety of blood and plasma products for the management of bleeding disorders have been achieved in recent decades. This has led some clinicians to believe that the infectious threat is over and that inhibitor formation is the foremost complication of hemophilia therapy. On the contrary, elimination of all microbes from blood is difficult, potentially impossible, and there are always threats from emerging pathogens. The risk of infection transmission is also increasing due to greater exposure to products, increasing prophylaxis and high-dose regimens for immune tolerance, and longevity of hemophilia patients. Current products can be considered "reasonably safe…

medicine.medical_specialtyLong term treatmentContext (language use)Hemophilia AInfectionsEmerging infectionsSAFERHumans; Blood Coagulation Disorders; Hemophilia A; Blood Transfusion; InfectionmedicineHumansBlood TransfusionIntensive care medicinePathogenTransmission (medicine)business.industryRisk of infectionTransfusion ReactionHematologyBlood Coagulation Disordersmedicine.diseaseSettore MED/07 - Microbiologia e Microbiologia ClinicaThrombosisSurgeryHemostasisPlasma productsBlood safetyCardiology and Cardiovascular MedicinebusinessInfectionSeminars in thrombosis and hemostasis
researchProduct